Meta-analysis of effects of bivalirudin versus heparin on myocardial ischemic and bleeding outcomes after percutaneous coronary intervention

AEB Perez, SV Rao, SJ Jolly, SB Pancholy… - The American Journal of …, 2016 - Elsevier
Bivalirudin is an alternative to unfractionated heparin (UFH) anticoagulation during
percutaneous coronary intervention. Previously, we have reported clinical benefit on major …

Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of …

C Briguori, G Visconti, A Focaccio, M Donahue… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: This study sought to assess the safety and the efficacy of bivalirudin compared
with unfractionated heparin (UFH) alone in the subset of patients at increased risk of …

Routine use of fluoroscopic-guided femoral arterial puncture to minimise vascular complication rates in CTO intervention: multi-centre UK experience

SL Fairley, AJ Lucking, M McEntegart, A Shaukat… - Heart, Lung and …, 2016 - Elsevier
Background Chronic total occlusion (CTO) revascularisation has a crucial role in
contemporary percutaneous coronary intervention (PCI). Procedural success is influenced …

Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials

M Verdoia, A Schaffer, L Barbieri, H Suryapranata… - Thrombosis …, 2015 - Elsevier
Bivalirudin has gained ground against unfractionated heparin (UFH) in percutaneous
coronary interventions (PCI), due to a reported better safety profile. However, whether …

Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors

F Abtahian, S Waldo, IK Jang - Catheterization and …, 2015 - Wiley Online Library
Objectives The primary objective of this study is the compare the association between
bleeding and the use unfractionated heparin (UFH) versus bivalirudin during percutaneous …

Biomarkers of Acute Kidney Injury and Scope of Utilization in the Cardiac Catheterization Laboratory

L Golestaneh, AM Basalely - … in the Cardiac Catheterization Laboratory: A …, 2020 - Springer
The risk of contrast induced acute kidney injury (CI-AKI) poses a challenge for ambulatory
cardiac procedures. The advent of more complicated procedures being performed on an …

Role of Parenteral Agents in PCI for Stable Patients

J Ghobrial, DA Burke, DS Pinto - … Cardiology: Principles and …, 2017 - Wiley Online Library
Optimal anticoagulation has proven to be a key component in the management of patients
undergoing percutaneous coronary intervention (PCI). Most data involving newer …

[引用][C] 急性冠脉综合征新型抗凝药物研究进展

王小东, 刘学波 - 国际心血管病杂志, 2015

[引用][C] 抗凝药物研究现况及进展

杨泽西, 张泽明, 胡鸿鹏, 徐变玲, 李星宇, 安蕾 - 国际呼吸杂志, 2015

[引用][C] TAVI

A Bartorelli, D Trabattoni